Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use

BACKGROUND: Ghana changed their antimalarial drug policy from monotherapies to Artemisinin-based Combination Therapies in 2004 in order to provide more efficacious medicines for treatment of malaria. The policy change can be eroded if poor quality Artemisinin-based Combination Therapies are allowed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Pharmacol Toxicol
Hlavní autoři: Tivura, Mathilda, Asante, Isaac, van Wyk, Albert, Gyaase, Stephaney, Malik, Naiela, Mahama, Emmanuel, Hostetler, Dana M., Fernandez, Facundo M., Asante, Kwaku Poku, Kaur, Harparkash, Owusu-Agyei, Seth
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084396/
https://ncbi.nlm.nih.gov/pubmed/27788677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-016-0089-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky